147 related articles for article (PubMed ID: 12859951)
81. Status epilepticus induces long lasting increase in S100A6 expression in astrocytes.
Jurewicz E; Bednarczyk J; Bot A; Lukasiuk K; Filipek A
Neurochem Res; 2013 Sep; 38(9):1941-8. PubMed ID: 23817846
[TBL] [Abstract][Full Text] [Related]
82. Interaction of S100A6 with Target Proteins In Vitro and in Living Cells.
Sakane K; Yamaguchi F; Tsuchiya M; Kondo R; Kanayama N; Magari M; Hatano N; Kobayashi R; Tokumitsu H
Methods Mol Biol; 2019; 1929():367-377. PubMed ID: 30710285
[TBL] [Abstract][Full Text] [Related]
83. Conservation of Specificity in Two Low-Specificity Proteins.
Wheeler LC; Anderson JA; Morrison AJ; Wong CE; Harms MJ
Biochemistry; 2018 Feb; 57(5):684-695. PubMed ID: 29240404
[TBL] [Abstract][Full Text] [Related]
84. Functional analysis of the human calcyclin gene promoter in a panel of human melanoma cell lines.
van Groningen JJ; Weterman MA; Swart GW; Bloemers HP
Biochem Biophys Res Commun; 1995 Aug; 213(3):1122-31. PubMed ID: 7654229
[TBL] [Abstract][Full Text] [Related]
85. Modulation of S-100 genes response to growth conditions in human epithelial tumor cells.
Matsumoto T; Murao S; Kito K; Kihana T; Matsuura S; Ueda N
Pathol Int; 1997 Jun; 47(6):339-46. PubMed ID: 9211520
[TBL] [Abstract][Full Text] [Related]
86. S100A6 represses Calu-6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis.
Wang T; Han S; Du G
Cell Biochem Funct; 2021 Aug; 39(6):771-779. PubMed ID: 34008212
[TBL] [Abstract][Full Text] [Related]
87. Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11.
Melle C; Ernst G; Schimmel B; Bleul A; von Eggeling F
PLoS One; 2008; 3(12):e3767. PubMed ID: 19048101
[TBL] [Abstract][Full Text] [Related]
88. Calcium- and cell cycle-dependent association of annexin 11 with the nuclear envelope.
Tomas A; Moss SE
J Biol Chem; 2003 May; 278(22):20210-6. PubMed ID: 12601007
[TBL] [Abstract][Full Text] [Related]
89. S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility.
Nedjadi T; Kitteringham N; Campbell F; Jenkins RE; Park BK; Navarro P; Ashcroft F; Tepikin A; Neoptolemos JP; Costello E
Br J Cancer; 2009 Oct; 101(7):1145-54. PubMed ID: 19724273
[TBL] [Abstract][Full Text] [Related]
90. S100A6 is a positive regulator of PPP5C-FKBP51-dependent regulation of endothelial calcium signaling.
Haldar B; Hamilton CL; Solodushko V; Abney KA; Alexeyev M; Honkanen RE; Scammell JG; Cioffi DL
FASEB J; 2020 Feb; 34(2):3179-3196. PubMed ID: 31916625
[TBL] [Abstract][Full Text] [Related]
91. [Clinical significance of S100A6 and Notch1 in multiple myeloma patients].
Bao HY; Wang Y; Wang JN; Song M; Meng QQ; Han X
Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):285-289. PubMed ID: 28468088
[No Abstract] [Full Text] [Related]
92. Expression levels of insulin-like growth factor binding proteins and insulin receptor isoforms in hepatoblastomas.
von Horn H; Tally M; Hall K; Eriksson T; Ekström TJ; Gray SG
Cancer Lett; 2001 Jan; 162(2):253-60. PubMed ID: 11146233
[TBL] [Abstract][Full Text] [Related]
93. Current view on cellular function of S100A6 and its ligands, CacyBP/SIP and Sgt1.
Filipek A; Leśniak W
Postepy Biochem; 2018 Oct; 64(3):242-252. PubMed ID: 30656909
[TBL] [Abstract][Full Text] [Related]
94. Increase caused by interleukin-6 in promoter activity of guinea pig liver transglutaminase gene.
Ikura K; Shinagawa R; Suto N; Sasaki R
Biosci Biotechnol Biochem; 1994 Aug; 58(8):1540-1. PubMed ID: 7765354
[TBL] [Abstract][Full Text] [Related]
95. Were Ancestral Proteins Less Specific?
Wheeler LC; Harms MJ
Mol Biol Evol; 2021 May; 38(6):2227-2239. PubMed ID: 33528559
[TBL] [Abstract][Full Text] [Related]
96. Lead-induced cytotoxicity and transcriptional activation of stress genes in human liver carcinoma (HepG2) cells.
Tchounwou PB; Yedjou CG; Foxx DN; Ishaque AB; Shen E
Mol Cell Biochem; 2004 Jan; 255(1-2):161-70. PubMed ID: 14971657
[TBL] [Abstract][Full Text] [Related]
97. Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain.
Khan MI; Dowarha D; Katte R; Chou RH; Filipek A; Yu C
PLoS One; 2019; 14(5):e0216427. PubMed ID: 31071146
[TBL] [Abstract][Full Text] [Related]
98. Heat shock activation of NFkB in rat liver is mediated by interleukin-1.
Pogliaghi G; Tacchini L; Anzon E; Radice L; Bernelli-Zazzera A
FEBS Lett; 1995 Sep; 372(2-3):181-4. PubMed ID: 7556665
[TBL] [Abstract][Full Text] [Related]
99. A hierarchical approach employing metabolic and gene expression profiles to identify the pathways that confer cytotoxicity in HepG2 cells.
Li Z; Srivastava S; Yang X; Mittal S; Norton P; Resau J; Haab B; Chan C
BMC Syst Biol; 2007 May; 1():21. PubMed ID: 17498300
[TBL] [Abstract][Full Text] [Related]
100. S100A6 as a Constituent and Potential Marker of Adult and Cancer Stem Cells.
Leśniak W; Filipek A
Stem Cell Rev Rep; 2022 Dec; 18(8):2699-2708. PubMed ID: 35796891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
